Y. Kruszynska

发表

Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.

D. S. Worrall, J. Olefsky, Y. Kruszynska, 2002, The Journal of clinical endocrinology and metabolism.

Effects of Nonesterified Fatty Acids on Glucose Metabolism After Glucose Ingestion

J. Olefsky, Y. Kruszynska, M. Mulford, 1997, Diabetes.

Muscle enzyme activity and insulin sensitivity in Type 1 (insulin-dependent) diabetes mellitus

K. Alberti, P. Home, Y. Kruszynska, 1986, Diabetologia.

Decreased insulin sensitivity and muscle enzyme activity in elderly subjects

K. Alberti, Y. Kruszynska, K. Alberti, 1988, European journal of clinical investigation.

Insulin insensitivity and skeletal muscle enzyme activities in response to overinsulinization in the rat.

K. Alberti, P. Home, Y. Kruszynska, 1987, Metabolism: clinical and experimental.

Hepatic Glycogen Metabolism and Insulin Receptor Status After Long-term Peripheral Insulin Delivery in the Islet-Transplanted Diabetic Rat

K. Alberti, P. Home, Y. Kruszynska, 1986, Diabetes.

Very low density lipoprotein metabolism after insulin over‐treatment and during a euglycaemic clamp

K. Alberti, P. Home, Y. Kruszynska, 1987, European journal of clinical investigation.

Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects.

Y. Kruszynska, M. Mulford, J. Yu, 1998, Diabetes.

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

R. A. Norman, A. Hevener, J. Olefsky, 2002, Diabetes.

Regulation of Glucose Metabolism in Skeletal Muscle

R. Henry, T. Ciaraldi, Y. Kruszynska, 2011 .

Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women.

J. Olefsky, Y. Kruszynska, J. Ofrecio, 2001, Diabetes.

Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion.

Y. Kruszynska, J. Frias, G. Macaraeg, 2000, Diabetes & metabolism.

Insulin Insensitivity in Type 1 Diabetes

P. Home, Y. Kruszynska, P. D. Home, 1987, Diabetic medicine : a journal of the British Diabetic Association.

Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.

J. Olefsky, Y. Kruszynska, J. Frias, 2003, Metabolism: clinical and experimental.

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

B. Sobel, J. Olefsky, Y. Kruszynska, 2000, Diabetes.

Type 2 Diabetes Mellitus: Etiology, Pathogenesis and Clinical Manifestations

Y. Kruszynska, 2004 .

Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus.

J. Olefsky, Y. Kruszynska, 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.

J. Olefsky, Y. Kruszynska, M. Mulford, 1999, Diabetes.

Comparison of portal and peripheral insulin delivery on carbohydrate metabolism in streptozotocin-diabetic rats

K. Alberti, P. Home, Y. Kruszynska, 1985, Diabetologia.

Comparison of Portal and Peripheral Insulin Delivery on Lipid Metabolism in Streptozocin-diabetic Rats

K. Alberti, P. Home, Y. Kruszynska, 1985, Diabetes.

Preservation of islet function and morphology after transplantation into high dose streptozotocin-diabetic rats.

K. Alberti, A. Morley, P. Home, 1986, Diabetes research.

Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.

M. Greenstone, P. Home, Y. Kruszynska, 1987, Thorax.

Night-time metabolic changes in normal subjects in the absence of the dawn phenomenon.

P. Home, Y. Kruszynska, 1988, Diabete & metabolisme.

Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

J. Olefsky, Y. Kruszynska, J. Frias, 2000, Diabetes care.

Methods in Diabetes Research, volume 1, parts A, B (1984), C (1985), Laboratory Methods edited by J. Larner and S. L. Pohl

Roy Taylor, P. Home, Y. Kruszynska, 1985 .

Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in a rat model of non-insulin-dependent diabetes

P. Home, Y. Kruszynska, 1988, Diabetologia.

Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.

J. Olefsky, Y. Kruszynska, J. Paterniti, 1998, The Journal of clinical investigation.

Alternative routes and methods of insulin delivery.

K. Alberti, P. Home, Y. Kruszynska, 1985, The Netherlands journal of medicine.

In Vivo Regulation of Liver and Skeletal Muscle Glycogen Synthase Activity by Glucose and Insulin

K. Alberti, P. Home, Y. Kruszynska, 1986, Diabetes.

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis

N. Mcintyre, P. Home, Y. Kruszynska, 1991, Hepatology.

Basal and 24-h C-peptide and insulin secretion rate in normal man

K. Alberti, P. Home, Y. Kruszynska, 2005, Diabetologia.

The relationship between insulin sensitivity and skeletal muscle enzyme activities in hepatic cirrhosis

P. Home, Y. Kruszynska, Y. Kruszynska, 1988, Hepatology.

Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis

N. Mcintyre, P. Home, Y. Kruszynska, 1991, Hepatology.

ffects of Troglitazone on Blood Concentrations of Plasminogen Activator Inhibitor 1 in Patients Wi t h Type 2 Diabetes and in Lean and Obese Normal

B. Sobel, J. Olefsky, Y. Kruszynska, 2000 .

Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia.

D. Accili, M. Reitman, J. Olefsky, 2000, Endocrinology.